Characterisation of a novel transcript LNPPS acting as tumour suppressor in bladder cancer via PDCD5‐mediated p53 degradation blockage-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Characterisation of a novel transcript LNPPS acting as tumour suppressor in bladder cancer via PDCD5‐mediated p53 degradation blockage

Published:2022-12-28 Issue:1 Volume:13 Page:
ISSN:2001-1326
Container-title:Clinical and Translational Medicine
language:en
Short-container-title:Clinical & Translational Med

Author:

Li Juan¹²,Wang Yifan¹,Zhang Xinya¹,Yang Xuemei¹²,Qi Qiuchen¹²,Mi Qi¹,Feng Maoxiao¹,Wang Yunshan¹²³,Wang Chuanxin¹²³,Li Peilong¹²,Du Lutao¹²³

Affiliation:

1. Department of Clinical Laboratory The Second Hospital Cheeloo College of Medicine Shandong University Jinan Shandong China

2. Shandong Engineering & Technology Research Center for Tumor Marker Detection Jinan Shandong China

3. Shandong Provincial Clinical Medicine Research Center for Clinical Laboratory Jinan Shandong China

Funder

National Natural Science Foundation of China

Key Technology Research and Development Program of Shandong

Natural Science Foundation of Shandong Province

Publisher

Wiley

Subject

Molecular Medicine,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ctm2.1149

Reference44 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Bladder Cancer

3. Bladder cancer

4. T1 bladder cancer: current considerations for diagnosis and management

5. Landmarks in the treatment of muscle-invasive bladder cancer

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. circKDM1A suppresses bladder cancer progression by sponging miR-889-3p/CPEB3 and stabilizing p53 mRNA;iScience;2024-04

2. dCas9 Tells Tales: Probing Gene Function and Transcription Regulation in Cancer;The CRISPR Journal;2024-04-01

3. The role of E3 ubiquitin ligases and deubiquitinases in bladder cancer development and immunotherapy;Frontiers in Immunology;2023-05-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3